Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | HMGCR | P04035 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL580817 | 1.00 | HTR2A (0.49) | HTR2ACYP3A4CYP19A1ALOX5PTGS2 | |
| SCHEMBL580350 | 1.00 | HTR2A (0.49) | HTR2ACYP3A4CYP19A1ALOX5PTGS2 | |
| SCHEMBL581243 | 1.00 | HTR2A (0.49) | HTR2ACYP3A4CYP19A1ALOX5PTGS2 | |
| SCHEMBL580783 | 1.00 | HTR2A (0.49) | HTR2ACYP3A4CYP19A1ALOX5PTGS2 | |
| SCHEMBL7090134 | 0.92 | TNKS2 (0.50) | HTR2ACYP3A4CYP19A1TNKS2TAAR1 | |
| SCHEMBL24783645 | 0.85 | TRAP1 (0.56) | HTR2ACYP3A4ALOX5PTGS2TNKS2 | |
| SCHEMBL30859419 | 0.85 | TRAP1 (0.56) | HTR2ACYP3A4ALOX5PTGS2TNKS2 | |
| SCHEMBL14894825 | 0.85 | TRAP1 (0.56) | HTR2ACYP3A4ALOX5PTGS2TNKS2 | |
| SCHEMBL24783634 | 0.85 | TRAP1 (0.56) | HTR2ACYP3A4ALOX5PTGS2TNKS2 | |
| SCHEMBL9509098 | 0.84 | TAAR1 (0.45) | HTR2ACYP3A4ALOX5PTGS2TNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2418191-A1 | Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same | Meiji Co., Ltd. (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-7893304-B2 | Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals comprising the same | MEIJI DAIRIES CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-02-05 | — | — | US | disclosed |
| EP-1854777-A1 | HYDROQUINONE LONG-CHAIN DERIVATIVE AND/OR PHENOXY LONG-CHAIN DERIVATIVE, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME | Meiji Dairies Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | NQO1, NDUFA10, UQCRC1 | HTR2A 337/4885CYP3A4 1584/4885CYP19A1 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.